107 related articles for article (PubMed ID: 3785481)
1. Effect of dipyridamole treatment on proteinuria in pediatric renal disease.
Ueda N; Kawaguchi S; Niinomi Y; Nonoda T; Ohnishi M; Ito S; Yasaki T
Nephron; 1986; 44(3):174-9. PubMed ID: 3785481
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
3. The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis.
Oner A; Tinaztepe K; Erdogan O
Pediatr Nephrol; 1995 Feb; 9(1):6-10. PubMed ID: 7742225
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.
Edström Halling S; Söderberg MP; Berg UB
Pediatr Nephrol; 2009 Jan; 24(1):91-7. PubMed ID: 18931859
[TBL] [Abstract][Full Text] [Related]
5. Clinical effect of dipyridamole in patients with IgA nephropathy.
Yagame M; Tomino Y; Miura M; Suga T; Endoh M; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1986 Nov; 11(5):329-33. PubMed ID: 2960035
[TBL] [Abstract][Full Text] [Related]
6. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
Woo KT; Edmondson RP; Yap HK; Wu AY; Chiang GS; Lee EJ; Pwee HS; Lim CH
Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
Kano K; Nishikura K; Yamada Y; Arisaka O
Clin Nephrol; 2003 Aug; 60(2):85-9. PubMed ID: 12940609
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide.
Flynn JT; Smoyer WE; Bunchman TE; Kershaw DB; Sedman AB
Am J Nephrol; 2001; 21(2):128-33. PubMed ID: 11359020
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical and persistent renal impairment in Henoch-Schönlein purpura after high-dose immunoglobulin therapy.
Blanco R; González-Gay MA; Ibáñez D; Sánchez-Andrade A; González-Vela C
Nephron; 1997; 76(2):247-8. PubMed ID: 9200429
[No Abstract] [Full Text] [Related]
10. Effects of dipyridamole on the short-term evolution of glomerulonephritis.
Camara S; de la Cruz JP; Frutos MA; Sanchez P; Lopez de Novales E; Sanchez E; Sanchez de la Cuesta F
Nephron; 1991; 58(1):13-6. PubMed ID: 1857478
[TBL] [Abstract][Full Text] [Related]
11. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.
Wu TH; Wu SC; Huang TP; Yu CL; Tsai CY
Nephron; 1996; 74(1):79-88. PubMed ID: 8883024
[TBL] [Abstract][Full Text] [Related]
12. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis.
Tanaka H; Suzuki K; Nakahata T; Ito E; Waga S
Pediatr Nephrol; 2003 Apr; 18(4):347-50. PubMed ID: 12700960
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.
Kamei K; Nakanishi K; Ito S; Ishikura K; Hataya H; Honda M; Nozu K; Iijima K; Shima Y; Yoshikawa N;
Pediatr Nephrol; 2015 Jun; 30(6):961-7. PubMed ID: 25487669
[TBL] [Abstract][Full Text] [Related]
14. [Demonstration of mesangial IgA deposits in kidney biopsies of pediatric patients: comparison with the clinical picture].
Kern BE; di Rocco D; Lütschg J; Lüthy C; Zimmermann A; Gerber HA; Oetliker OH; Bianchetti MG
Praxis (Bern 1994); 1995 Oct; 84(41):1158-64. PubMed ID: 7481326
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Preliminary results of a prospective uncontrolled trial.
Rostoker G; Desvaux-Belghiti D; Pilatte Y; Petit-Phar M; Philippon C; Deforges L; Terzidis H; Intrator L; André C; Adnot S
Nephron; 1995; 69(3):327-34. PubMed ID: 7753269
[TBL] [Abstract][Full Text] [Related]
16. Henoch Schönlein nephritis: clinical findings related to renal function and morphology.
Halling SF; Söderberg MP; Berg UB
Pediatr Nephrol; 2005 Jan; 20(1):46-51. PubMed ID: 15503170
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of prednisone treatment in children with IgA nephropathy and Schönlein-Henoch nephropathy according to the Waldo protocol with regard to pathomorphologic changes in renal biopsy].
Szymanik-Grzelak H; Mizerska-Wasiak M; Roszkowska-Blaim M
Pol Merkur Lekarski; 2001 Apr; 10(58):259-62. PubMed ID: 11434171
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide in addition to steroids improves proteinuria and renal function in adult Henoch-Schoenlein nephritis with nephrotic proteinuria.
Zhang Y; Gao Y; Zhang Z; Liu G; He H; Liu L
Nephrology (Carlton); 2014 Feb; 19(2):94-100. PubMed ID: 24171710
[TBL] [Abstract][Full Text] [Related]
19. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis.
Hara M; Yanagihara T; Kihara I
Clin J Am Soc Nephrol; 2007 Mar; 2(2):231-8. PubMed ID: 17699418
[TBL] [Abstract][Full Text] [Related]
20. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Shima Y; Nakanishi K; Kamei K; Togawa H; Nozu K; Tanaka R; Sasaki S; Iijima K; Yoshikawa N
Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
